Vecuronium Side Effects
Medically reviewed by Drugs.com. Last updated on Mar 2, 2022.
For the Consumer
Applies to vecuronium: parenteral powder for injection
A standardized concentration for this drug has been established through Standardize 4 Safety (S4S), a national patient safety initiative to reduce medication errors, especially during transitions of care. The drug is included in a standard concentration list which may apply to an IV or oral compounded liquid formulation. For additional information, see the ASHP website [Web].
Side effects include:
Skeletal muscle weakness.
For Healthcare Professionals
Applies to vecuronium: intravenous powder for injection, intravenous solution
Rare (0.01% to 0.1%): Prolonged neuromuscular block
Very rare (less than 0.01%): Flaccid paralysis, muscular weakness, steroid myopathy[Ref]
Very rare (less than 0.01%): Bronchospasm, airway complication of anesthesia[Ref]
Very rare (less than 0.01%): Injection site pain, injection site reaction[Ref]
Rare (0.01% to 0.1%): Decreased drug effect/therapeutic response, increased drug effect/therapeutic response
Rare (less than 0.1%): Delayed recovery from anesthesia[Ref]
Very rare (less than 0.01%): Circulatory collapse, shock, flushing[Ref]
More about vecuronium
Related treatment guides
1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
2. Cerner Multum, Inc. "Australian Product Information." O 0
3. "Product Information. Vecuronium Bromide (vecuronium)." Hospira Inc, Lake Forest, IL.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.